Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06268704 · ClinicalTrials.gov registry record · Phase 4
Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection
A Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, sponsored by University of New Mexi.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 230
- Enrollment target
- 1
- Study location
NCT06268704: Recruiting Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, sponsored by University of New Mexi.
NCT06268704 is a Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 230 participants, above the 137-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (68% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06268704, a Phase 4 study of Sacroiliac Joint Dysfunction and Sacro-Iliac Spondylosis, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 230 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Methylprednisolone
- DRUG 2% Lidocaine HCl Injection
Study Locations (1)
New Mexico
- University of New Mexico Hospital - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2027-05-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06268704
The ClinicalTrials.gov registry entry for NCT06268704 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 137-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (68% higher). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sacroiliac Joint Dysfunction appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.
NCT06268704 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.
Frequently Asked Questions
What is clinical trial NCT06268704 about?
NCT06268704 is a clinical study titled "Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection". This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.
What is the current status of trial NCT06268704?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 230 participants. The study started on 2024-03-27. Estimated completion is 2027-05-01.
What conditions does trial NCT06268704 study?
This clinical trial studies the following conditions: Sacroiliac Joint Dysfunction, Sacro-Iliac Spondylosis.
What interventions are being tested in trial NCT06268704?
The interventions under investigation include: Dexamethasone (DRUG), Methylprednisolone (DRUG), 2% Lidocaine HCl Injection (DRUG).
Who is sponsoring clinical trial NCT06268704?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06268704 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliac Joint Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.